CATH Classification
| Level | CATH Code | Description | 
|---|---|---|
 
	 | 
    1 | Mainly Alpha | 
 
	 | 
    1.10 | Orthogonal Bundle | 
 
	 | 
    1.10.510 | Transferase(Phosphotransferase); domain 1 | 
 
	 | 
    1.10.510.10 | Transferase(Phosphotransferase) domain 1 | 
Domain Context
CATH Clusters
| Superfamily | Transferase(Phosphotransferase) domain 1 | 
| Functional Family | Glycogen synthase kinase-3 beta | 
Enzyme Information
| 2.7.11.1 | 
							 Non-specific serine/threonine protein kinase. 
							based on mapping to UniProt P49841 		
							ATP + a protein = ADP + a phosphoprotein. 
							-!- This is a heterogeneous group of serine/threonine protein kinases that do not have an activating compound and are either non-specific or their specificity has not been analyzed to date. -!- Formerly EC 2.7.1.37 and EC 2.7.1.70. 
						 | 
					
| 2.7.11.26 | 
							 [Tau protein] kinase. 
							based on mapping to UniProt P49841 		
							ATP + [tau protein] = ADP + [tau protein] phosphate. 
							-!- Activated by tubulin. -!- Involved in the formation of paired helical filaments, which are the main fibrous component of all fibrillary lesions in brain and are associated with Alzheimer's disease. -!- Formerly EC 2.7.1.135. 
						 | 
					
UniProtKB Entries (1)
| P49841 | 
						 GSK3B_HUMAN 
						Homo sapiens 
						Glycogen synthase kinase-3 beta 
					 | 
				
PDB Structure
| PDB | 3GB2 | 
| External Links | |
| Method | X-RAY DIFFRACTION | 
| Organism | |
| Primary Citation | 
					 2-{3-[4-(Alkylsulfinyl)phenyl]-1-benzofuran-5-yl}-5-methyl-1,3,4-oxadiazole derivatives as novel inhibitors of glycogen synthase kinase-3beta with good brain permeability. 
					    
					    J.Med.Chem. 
					    
					 | 
			
